CYNO ended its first day of trades at $18.93 a share, up 26% over its IPO price of $15 a share.
The medical device maker raised $75 million by offering five million shares priced above its $12-$14 a share estimated range.
Cynosure's majority shareholder is Italian laser maker El.En. S.p.A., which sold a million shares in the IPO out of the total offering of five million shares.
After the IPO, El.En will hold 38% of Cynosure, retaining control due to the dual class shares.
Cynosure makes laser treatment systems used for hair removal, vascular lesions, and skin rejuvenation.
The company reported net income of $1.6 million and revenue of $40 million in the nine months ending Sept. 30, compared with net income of $4.5 million and revenue of $29.4 million in the year-ago period.
Know how to make God laugh? Tell Her your plans ....